AC Immune (ACIU) Treasury Shares (2020 - 2026)

AC Immune (ACIU) has reported Treasury Shares for 7 consecutive years, with -$278.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares fell 114712.68% year-over-year to -$278.4 million; the TTM figure through Mar 2026 stood at -$278.4 million (down 114712.68% YoY), while the FY2025 annual figure was -$262.9 million, down 105559.69% from the prior year.
• Treasury Shares eased to -$278.4 million in Q1 2026 per ACIU's latest filing, from -$272.8 million in the prior quarter.
• Across five years, Treasury Shares topped out at $13.6 million in Q4 2025 and bottomed at $5.9 million in Q4 2023.
• Historically, Treasury Shares has averaged $9.2 million across 5 years, with a median of $6.7 million in 2021.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 100.1% — and 2026, when it sank 114712.68%.
• AC Immune's Treasury Shares stood at $128714.7 in 2022, then plunged by 92064.79% to -$118.4 million in 2023, then jumped by 99.79% to -$248851.8 in 2024, then tumbled by 109505.42% to -$272.8 million in 2025, then declined by 2.06% to -$278.4 million in 2026.
• Business Quant data shows ACIU's Treasury Shares at -$278.4 million in Q1 2026, -$272.8 million in Q4 2025, and -$272523.9 in Q3 2025.